LITTLE ROCK, Ark. (July 21, 2020) –SCA Pharma, an FDA‐registered outsourcing facility, today announced that it will expand its operations in Little Rock. SCA will be investing more than $10 million and will create the opportunity to double its current Little Rock workforce of 180 people. Additionally, the investment will allow SCA Pharma to renovate an existing 42,000‐square‐foot facility at the Little Rock Municipal Airport Business Park and construct an additional 20,000‐square‐foot facility adjacent to the existing facility. SCA announced last week that there is also a planned forty percent expansion of its Windsor, CT facility.
Read MoreTo our team members, colleagues & friends –
Recent events across our country have reignited the deep issue of racial discrimination. The deaths of George Floyd, Breonna Taylor, Ahmaud Arbery and countless other black Americans have brought needed global attention to the systemic injustice in the fabric of our society.
The Enhanced Healthcare Partners leadership team recognizes the enormity of the problems before us. As an organization and as fellow humans, we must do our part to end racism, injustice and violence. We are working and will continue to help build businesses that stand for positive change in our society. With this note, we hope to convey our solidarity with black lives in communities around the world.
The new platform will be well-positioned to offer hospital systems a suite of solutions to drive patient care, physician satisfaction and hospital efficiencies.
We are excited to announce our joint investment in the business merger of Synergy Surgicalists—one of the nation's top providers of surgicalist staffing in the acute care setting—and EA Health—the nation’s leading provider of specialty physician on-call compensation solutions and physician staffing services.
Read MoreGREENVILLE, SC – Pharmaceutical Associates Inc (“PAI”), a leader in liquid unit-dose, bottle prescription, and over-the-counter medications, announced today the appointment of Paul Campanelli, former CEO of Endo Pharmaceuticals to its Board of Directors.
Read MoreWe are excited to announce the successful exit from our platform investment in West Dermatology through the sale of the business to Sun Capital Partners, Inc. Over the course of EHP's ownership, the company doubled the number of its clinics, acquired 22 practices and completed numerous organic expansion initiatives.
Read MoreNEW YORK, NY (Dec. 17, 2019) — Enhanced Healthcare Partners (“EHP”), a leading New York-based private equity firm focused on investing in middle-market healthcare businesses, today announced the appointment of Dave Prendergast as Vice President – Business Development, effective immediately.
Mr. Prendergast joins EHP to lead the firm’s business development efforts, where he will focus on identifying investment opportunities in founder and entrepreneur-led lower middle-market healthcare businesses in North America, targeting platforms between $50 and $250 million in enterprise value in the healthcare services sector including provider-based services, pharma services, payor services and technology-enabled services.
Read More